Biomay Expands DNA Manufacturing Portfolio with Cell-free Enzymatic DNA Synthesis
(October 26, 2026) New technology complements Biomay’s established plasmid DNA manufacturing capabilities. As the result of focused internal research and development, the company has filed a patent application earlier this year. Biomay is now implementing the technology for GMP manufacturing, with the first GMP batches completed by end of this year.
> More info